CClinicalTrials.gg
RecruitingNCT07466589Updated Mar 12, 2026

Advancement of Vestibular Intervention Via Portable Electrical Stimulator (VIPES)

An interventional study of Stochastic Galvanic Vestibular Stimulation (sGVS) in Mild Traumatic Brain Injury, Concussion, sponsored by Vivonics, Inc.. Recruiting at 1 site in United States. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-03-12.

Sponsored by Vivonics, Inc. · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2026, 7 months ago, but the record still lists the study as recruiting.
  • Started Aug 2025; still recruiting 1 year 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Not applicable
Ages
18 Years to 55 Years
Sex
All
01

Study summary

The goal is to assess the potential benefit of stochastic galvanic vestibular stimulation (sGVS) in improving patient performance with respect to balance, gait, and/or overall vestibular function for individuals with known deficits in vestibular performance as a result of a mild traumatic brain injury (mTBI).

Read the detailed description

The VIPES system that delivers sGVS is a small wearable device that administers stimulation aiming to improve the function of a vestibular system that has been adversely affected by mild TBI, concussion. In particular VIPES is designed to provide stimulus comprising random noise in a low frequency band (0 to 5Hz maximum) below the level of perception by the subject. The VIPES system consists of the four electrodes (two behind each ear). The stimulator can deliver the stimulation in multiple directions and receive information about the amplitude delivered accounting for skin impedance. The Bertec Portable Essential's dual-balance plate balance system and the APDM Opal V2R sensor are used as reference measurement tools for assessing clinical performance.

The study to be completed is an N=32 single-arm clinical investigation, comprised of a within-subject crossover study designed to evaluate whether electrical stimulation delivered by a wearable vestibular system can improve functional performance on clinical balance and mobility assessments. All participants will complete both Timed Up and Go (TUG) and mCTSIB + COBALT performance tests under a series of stimulation conditions.

Each test session begins with a Baseline (no stimulation) trial, followed by four additional trials under different stimulation levels: 0mA (sham), 0.33mA, 0.67mA, and 1.0mA. The stimulation sequence is randomized after Baseline. Participants are blinded to stimulation level during all trials.

Participants will be recruited from the pool of patients treated at the University of Michigan - NeuroSport Clinic for mTBI. Upon passing pre-screening through chart review and via phone, interested individuals will be scheduled for a study visit that begins with obtained informed consent. Prior to beginning the testing procedures, enrolled participants will provide demographic information (age, sex/gender, race, ethnicity), have height measured, weight measured, and provide a detailed medical history, history of present illness, a list of current medications, as well as complete a post-concussion symptoms questionnaire.

The performance tests to be completed:

  1. Modified Clinical Test of Sensory Integration on Balance (mCTSIB):

    Tool: Bertec Portable Essential's dual-balance plate balance system

    Rationale: mCTSIB is a balance test commonly used to evaluate individuals of all ages post-concussion. This test protocol assesses how well an individual uses sensory input when one or more sensory systems are compromised. This protocol is commonly used to evaluate individuals post-concussion to describe static balance ability.

    The test will be performed for each sGVS amplitudes from 0mA (sham \& baseline) to 1 mA at 0.33 mA increments. Two trials for each of the following conditions:

    • Standard (eyes open on firm surface)
    • Proprioception (eyes closed on firm surface)
    • Vision (eyes open on foam surface)
    • Vestibular (eye closed on foam surface)
  2. COBALT Balance Test:

    Tool: Bertec Portable Essential's dual-balance plate balance system

    Rationale: COBALT is a balance test commonly used to evaluate individuals post-concussion. This test protocol places high demand on the visual and vestibular systems that is not provided by traditional balance tests. These higher demand conditions improve sensitivity in detecting balance dysfunction in those post-concussion.

    The test will be performed for each sGVS currents from 0mA (sham \& baseline) to 1 mA at 0.33 mA increments. Two trials for each of the following conditions/surfaces:

    On Firm Surface:

    • Head Shake - Standing on firm surface with feet apart, head movement*

      • Normal stance with headshake and eyes closed. The subject will be instructed to stand still, with hands on hips and then asked to adjust head positioning approximately 30 degrees from a center position in sync with a metronome set at 120 beats/min.
      • Participant will practice with eyes open and when ready close eyes.
    • Visual Motion Sensitivity - Visual motion sensitivity condition on firm surface.

      • The subject is instructed to stand at the center of the balance plate with feet together and both arms extended out in front with hands clasped together and the thumbs straight up. The subject is to focus on the thumbs held in front while rotating approximately 30 degrees right and left, for a total excursion of 60 degrees, in sync with the metronome set at 40 beats/min.

    On Foam Surface:

    • Head Shake - Standing on foam with feet apart, head movement*

      o Normal stance with head shake and eyes closed on foam. Performed with the foam pad placed on the balance plate with the same procedure and parameters as HS on firm surface described above.

    • Visual Motion Sensitivity - Visual motion sensitivity condition on foam. o Performed with the foam pad placed on the balance plate with the same procedure and parameters as VMS condition on firm surface described above.
  3. Timed up and go (TUG):

Tool: Opal V2R Sensor

Rationale: TUG is a test used to assess an individual's functional balance. It requires appropriate static and dynamic balance system integration. TUG provides a measure of functional balance integration not provided from standing balance tasks.

The test will be performed for each GVS amplitudes from 0mA (sham \& baseline) to 1 mA at 0.33 mA increments.

  • The subject starts in a seated position
  • The subject stands up upon research staff command: walks 3 meters, turns around, walks back to the chair and sits down.
  • The time stops when the patient is seated.

Participants take a break following the testing prior to repeating. Following completion of the study, participants are asked to completed a short System Usability Scale Questionnaire. The entire study visit is estimated to take about 120 minutes.

The overall aim of the study is to determine whether performance improves under active stimulation conditions when compared to sham trials. Results may inform optimal parameter selection for future efficacy-focused studies.

02

Conditions studied

  • Mild Traumatic Brain Injury, Concussion

Browse trials for

Keywords

  • mTBI
  • mild traumatic brain injury
  • concussion
  • balance
  • gait
  • vestibular
  • GVS
03

In context

Brain Concussion

530 studies on the registry are indexed under Brain Concussion; 151 are open to participants now.

This study's planned enrollment of 32 is below the median of 64 across 364 interventional studies indexed under Brain Concussion.

Browse Brain Concussion studies →

Lead sponsor

This is the only study on the registry with Vivonics, Inc. as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age 18-55
  2. Diagnosed with concussion, evaluated at the University of Michigan
  3. Symptoms persistent greater than 4-6 weeks
  4. Self-reported imbalance
  5. Must be able to attend in-person session.

No racial/ethnic groups will be excluded, although all participants must be fluent speakers of English.

Exclusion criteria

Exclusion Criteria:

  1. Anyone under the age of 18 or over the age of 55
  2. Presence of prior diagnosis of peripheral vestibulopathy
  3. Women who are pregnant
  4. Inability to complete testing (e.g., severe symptom burden, inability to stand unassisted).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    All Participants: Randomized Stimulation Sequence

    All participants complete all performance test types (TUG and mCTSIB + COBALT), and complete each performance test under all stimulation levels (Baseline + 0mA + 0.33mA + 0.67mA + 1.0mA). Test order and stimulation sequence are randomized.

    Device: Stochastic Galvanic Vestibular Stimulation (sGVS)

Interventions

  • DeviceStochastic Galvanic Vestibular Stimulation (sGVS)

    The investigational intervention is a non-invasive, wearable vestibular stimulation system that delivers subsensory electrical stimulation via surface electrodes behind the ears. Stimulation is delivered at one of four levels (0.33mA, 0.67mA, 1.0mA, and 0mA sham) during standard clinical balance and mobility assessments (TUG and BERTEC). Participants are blinded to stimulation level during each trial.

06

What researchers measure

Primary outcomes

  1. Change in Postural Sway during mCTSIB Across Stimulation Conditions

    Comparison of sway area (deg/s) during mCTSIB at stimulation conditions (0.33mA, 0.67mA, and 1mA) in comparison to randomized Sham (0mA).

    Time frame: Performance assessed when VIPES is worn and patient is completing the testing procedure.

  2. Change in TUG Time to Completion

    Comparison of time to complete the Timed Up and Go (TUG) test (seconds) at stimulation conditions (0.33mA, 0.67mA, and 1mA) in comparison to randomized Sham (0mA).

    Time frame: Performance assessed when VIPES is worn and patient is completing the testing procedure.

  3. Change in Postural Sway during COBALT

    Comparison of sway area (deg/s) during COBALT at stimulation conditions (0.33mA, 0.67mA, and 1mA) in comparison to randomized Sham (0mA).

    Time frame: Performance assessed when VIPES is worn and patient is completing the testing procedures

07

Study locations

1 of 1 sites recruiting
  • University of Michigan, Michigan Medicine
    Ann Arbor, Michigan 48109, United States
    • Deb Demski, MUP, MSW, CCRP · Contact · darfy@med.umich.edu · 734-647-2147
    • Matthew Morley, MA · Contact · morleymm@umich.edu · 734-647-3326
    • Devin L McCaslin, PhD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07466589
Lead sponsor
Vivonics, Inc.
Collaborators
University of Michigan
Responsible party
Sponsor
First posted
Mar 12, 2026
Start date
Aug 22, 2025
Primary completion
Mar 2026 (estimated)
Completion
Mar 2026 (estimated)
Last update
Mar 12, 2026

Study contacts

Joshua Colls, B.S.
Contact
jcolls@vivonics.com
781-373-1930 ext. 263
Deb Demski, MUP, MSW, CCRP
Contact
darfy@med.umich.edu
734-647-2147
Devin L McCaslin, PhD
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion